Therapeutic Versatility of L-Arginine as a Nutraceutical Supplement: Biochemical Pathways, Clinical Evidence, and Regulatory Perspectives
International Journal of Drug Delivery Technology · 17.06.2026 · 16 (54s)
DOI: 10.25258/ijddt.16.54s.48 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Sayali Kamble und 5 weiteren Autor:innen.
Abstract (Originalsprache)
L-arginine is a conditionally essential amino acid that is located in the centre of positions in the human metabolism because of its use as a building block of nitric oxide, urea, polyamines, and creatine. Over the last few years, there has been increasing interest in nutraceuticals thereby bringing about the widespread use of L-arginine supplements to cardiovascular, metabolic, immune, reproductive, and performance related advantages. The biochemical part shows that arginine participates in nitric oxide synthase mechanisms, urea cycle and polyamine and creatine synthesis with a greater focus on the regulation of nitric oxide synthase and arginase activity. Randomized controlled trials and meta-analyses showing small improvements in endothelial and blood pressure functions and selected outcomes in erectile dysfunction and exercise recovery clinical evidence would suggest that results in metabolic and neurological disorders are varied. The safety assessments reveal that L-arginine is safe at the typical dosages, however, care should be taken in certain groups of the population, as well as when used alongside vasodilatory drugs. The regulatory review proves that L-arginine is internationally treated as a nutraceutical or dietary supplement, and the level of control over it differs among different jurisdictions, including the United States, the European Union, and India. In general, the review highlights that though Larginine has biologically significant and clinically potential application as a nutraceutical, it has some benefits that are scenario-specific and need to be based on evidence-backed dosage, attention towards patient-specificity, and adherence to regulatory principles.
Zitieren
APA
Kamble, S., Gadad, A., Mane, M., Kamble, R., Kamble, S., & Patil, S. (2026). Therapeutic Versatility of L-Arginine as a Nutraceutical Supplement: Biochemical Pathways, Clinical Evidence, and Regulatory Perspectives. International Journal of Drug Delivery Technology, 16(54s). https://doi.org/10.25258/ijddt.16.54s.48
Vancouver
Kamble S, Gadad A, Mane M, Kamble R, Kamble S, Patil S. Therapeutic Versatility of L-Arginine as a Nutraceutical Supplement: Biochemical Pathways, Clinical Evidence, and Regulatory Perspectives. International Journal of Drug Delivery Technology. 2026;16(54s). doi:10.25258/ijddt.16.54s.48
BibTeX
@article{Kamble2026,
author = {Kamble, Sayali and Gadad, Anand and Mane, Manisha and Kamble, Rohan and Kamble, Samruddhi and Patil, Shradha},
title = {Therapeutic Versatility of L-Arginine as a Nutraceutical Supplement: Biochemical Pathways, Clinical Evidence, and Regulatory Perspectives},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {54s},
doi = {10.25258/ijddt.16.54s.48}
}
EUVIMED